{"id":"W4408868147","doi":"10.1038/s41408-025-01243-7","title":"Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development","year":2025,"lang":"en","type":"erratum","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Refractory (planetary science); Drug development; Internal medicine; Drug; Oncology; Intensive care medicine; Pharmacology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002152665,0.0004769418,0.001407356,0.0008187245,0.0002459198,0.00005756814,0.0005164901,0.0005931145,0.0005975986],"category_scores_gemma":[0.001890017,0.0002950639,0.0003535917,0.0007762765,0.0001748161,0.00007583424,0.0001902,0.006559425,0.00001276331],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000994016,"about_ca_system_score_gemma":0.01331059,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001406005,"about_ca_topic_score_gemma":0.03101957,"domain_scores_codex":[0.9947119,0.0007805533,0.002063898,0.0005463258,0.001125278,0.0007720364],"domain_scores_gemma":[0.9967675,0.001037894,0.0009204154,0.000510342,0.000379504,0.0003843763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.003895461,0.002753919,0.1804667,0.000371717,0.001315525,0.003006721,0.0007858222,0.00001211737,0.00001688793,0.000001642518,0.7183467,0.08902675],"study_design_scores_gemma":[0.02637111,0.0006579021,0.6022682,0.01261289,0.0005377702,0.001054766,0.0008057959,0.0002246173,0.0003833255,0.00001281788,0.3546867,0.0003840799],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.6386059,0.1094443,0.00005836389,0.0256317,0.1559737,0.007788742,0.000546404,0.0001673078,0.06178355],"genre_scores_gemma":[0.2784295,0.06503282,0.001136754,0.0005378402,0.005213002,0.0004164194,0.0002444771,0.0001583591,0.6488308],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5870473,"threshold_uncertainty_score":0.9999502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07078477127089412,"score_gpt":0.3992426327131807,"score_spread":0.3284578614422866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}